Shareen Doak

From Wikipedia, the free encyclopedia

Shareen Heather Doak
Born (1978-12-01) 1 December 1978 (age 45)
NationalityBritish
Academic background
Alma materSwansea University
Doctoral advisorJim Parry
Liz Parry
Academic work
DisciplineToxicology
Sub-disciplineNanotoxicology
InstitutionsSwansea University Medical School

Professor Shareen Heather Doak FLSW (born 1 December 1978) holds a personal chair in Genotoxicology and Cancer at Swansea University and is a leading female British scientist in the field of Nanotoxicology globally.[1]

Education[edit]

Doak was educated in Saudi Arabia in her early years before returning to the UK to complete her A levels at St. Michaels School in Llanelli, South Wales. She studied for a Bachelor of Science (BSc) in genetics at Swansea University, and obtained a 1st class honors degree in 2000. Remaining at Swansea University, Doak completed her PhD in oncology and cancer biology at the genetics department in 2003 under the supervision of Professor Jim Parry[2] and Dr. Liz Parry.

Career[edit]

After working for a short period as a post-doctoral researcher and genetics tutor at Swansea University, on research projects including biomarkers for prostate cancer and identifying thresholds dose-response for direct-acting genotoxins, Doak gained a Research Councils UK (RCUK) Academic Fellowship in 2007 which was supported by both the Swansea University Medical School and the Swansea University College of Engineering at Swansea University. In 2014, Doak was promoted to a personal chair in Genotoxicology and Cancer, as one of the youngest scientists to be awarded a professorship at Swansea University. Alongside her research projects in nano(geno)toxicology, In Vitro toxicology, and prostate cancer,[3] Doak is director of the Centre for NanoHealth[4] at Swansea University Medical School]as well as being a UK and EUROTOX Registered Toxicologist.[citation needed] In 2018, Doak was elected a Fellow of the Learned Society of Wales.[5]

Recent grants[edit]

Year Grant
2017 Celtic Advanced Life Science Innovation Network (CALIN) - €11.96M[6][7]
2017 Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS)[8] - €13M

References[edit]

  1. ^ "Professor Shareen Doak staff page". Swansea University medical School. Retrieved 18 May 2015.
  2. ^ "Mutagenesis journal tribute". academic.oup.com. 1 January 2011. Retrieved 29 December 2017.
  3. ^ "Professor Shareen Doak | Expertise Wales". businesswales.gov.wales. Retrieved 30 September 2017.
  4. ^ University, Bangor. "Keynote speakers". www.nrn-lcee.ac.uk. Retrieved 30 September 2017.
  5. ^ Wales, The Learned Society of. "Shareen Doak". The Learned Society of Wales. Retrieved 29 August 2023.
  6. ^ "CALIN – New Life Science Innovation Network for Welsh and Irish businesses launched - Hwb Gwyddorau Bywyd Cymru | Life Sciences Hub Wales". Hwb Gwyddorau Bywyd Cymru | Life Sciences Hub Wales. Retrieved 30 September 2017.
  7. ^ "New Network Launched to Assist Irish and Welsh Life Science Businesses Innovate | UKSPA". www.ukspa.org.uk. Retrieved 30 September 2017.
  8. ^ "Swansea experts' futuristic role in making next-gen products - cruelty free". swanseabaytimes.com. Retrieved 30 September 2017.